EMAIL THIS PAGE TO A FRIEND

Oncotarget

Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway.


PMID 28969041

Abstract

Aplysin, a bromosesquiterpene isolated from Aplysia kurodai, was explored as a potential anti-breast cancer agent by us. However, the mechanisms underlying the anticarcinogenic effect of aplysin remain unclear. Here, aplysin was found to remarkably suppress tumor growth